Literature DB >> 18711402

Full-length hdmX transcripts decrease following genotoxic stress.

M Markey1, S J Berberich.   

Abstract

Previous studies have suggested that the mdmX gene is constitutively transcribed, and that MdmX protein activity is instead controlled by cellular localization and DNA damage induced Mdm2-mediated ubiquitination leading to proteasomal degradation. In these studies, we report that the human mdmX (hdmX) mRNA is reproducibly decreased in various human cell lines following treatment with various DNA-damaging agents. Repression of hdmX transcripts is observed in DNA-damaged HCT116 colon cancer cells and in isogenic p53(-/-) cells, suggesting that this effect is p53-independent. Reduction in the amount of hdmX transcript occurs in both human tumor cell lines and primary human diploid fibroblasts, and results in a significant reduction of HdmX protein. Examination of hdmX promoter activity suggests that damage-induced repression of hdmX mRNA is not significantly impacted by transcription initiation. In contrast, changes in hdmX mRNA splicing appear to partly explain the reduction in full-length hdmX mRNA levels in tumor cell lines with the destabilization of full-length hdmX transcripts, potentially through microRNA miR-34a regulation, also impacting transcript levels. Taken together, this study uncovers previously unrecognized cellular mechanisms by which hdmX mRNA levels are kept low following genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711402      PMCID: PMC2610866          DOI: 10.1038/onc.2008.266

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

2.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

3.  Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.

Authors:  Domenico Migliorini; Davide Danovi; Emanuela Colombo; Roberta Carbone; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

4.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

5.  Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Authors:  R Honda; H Yasuda
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

6.  Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2.

Authors:  Petra de Graaf; Natalie A Little; Yolande F M Ramos; Erik Meulmeester; Stef J F Letteboer; Aart G Jochemsen
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

7.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

8.  Comparative study of the p53-mdm2 and p53-MDMX interfaces.

Authors:  V Böttger; A Böttger; C Garcia-Echeverria; Y F Ramos; A J van der Eb; A G Jochemsen; D P Lane
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

9.  "Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells".

Authors:  Isao Eto
Journal:  Cancer Cell Int       Date:  2006-08-09       Impact factor: 5.722

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  17 in total

1.  HdmX overexpression inhibits oncogene induced cellular senescence.

Authors:  Kelly R Miller; Kevin Kelley; Rebecca Tuttle; Steven J Berberich
Journal:  Cell Cycle       Date:  2010-08-23       Impact factor: 4.534

Review 2.  The emerging functions of the p53-miRNA network in stem cell biology.

Authors:  Chao-Po Lin; Yong Jin Choi; Geoffrey G Hicks; Lin He
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

3.  Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines.

Authors:  Hélène Albert; Eric Battaglia; Carolino Monteiro; Denyse Bagrel
Journal:  Mol Oncol       Date:  2012-07-27       Impact factor: 6.603

4.  Role of miR-34c microRNA in the late steps of spermatogenesis.

Authors:  Frantz Bouhallier; Nathalie Allioli; Fabrice Lavial; Frédéric Chalmel; Marie-Hélène Perrard; Philippe Durand; Jacques Samarut; Bertrand Pain; Jean-Pierre Rouault
Journal:  RNA       Date:  2010-02-11       Impact factor: 4.942

5.  Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen-induced cellular senescence.

Authors:  Rebecca Tuttle; Kelly R Miller; J Nicholas Maiorano; Paula M Termuhlen; Yongping Gao; Steven J Berberich
Journal:  Int J Cancer       Date:  2011-08-09       Impact factor: 7.396

6.  YPEL3, a p53-regulated gene that induces cellular senescence.

Authors:  Kevin D Kelley; Kelly R Miller; Amber Todd; Amy R Kelley; Rebecca Tuttle; Steven J Berberich
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

7.  HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.

Authors:  Anna Phillips; Amina Teunisse; Suzanne Lam; Kirsten Lodder; Matthew Darley; Muhammad Emaduddin; Anja Wolf; Julia Richter; Job de Lange; Matty Verlaan-de Vries; Kristiaan Lenos; Anja Böhnke; Frank Bartel; Jeremy P Blaydes; Aart G Jochemsen
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 8.  Apoptosis in leukemias: regulation and therapeutic targeting.

Authors:  Ismael Samudio; Marina Konopleva; Bing Carter; Michael Andreeff
Journal:  Cancer Treat Res       Date:  2010

Review 9.  MDM2, MDMX and p53 in oncogenesis and cancer therapy.

Authors:  Mark Wade; Yao-Cheng Li; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

10.  MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame.

Authors:  Pooja Mandke; Nicholas Wyatt; Jillian Fraser; Benjamin Bates; Steven J Berberich; Michael P Markey
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.